Abstract
The Q61R mutation of the NRAS gene is one of the most frequent driver mutations of thyroid cancer. Tumors with this mutation are characterized by invasion into blood vessels and formation of distant metastases. To study the role of this mutation in the growth of thyroid cancer, we developed a model system on the basis of thyroid epithelial cell line Nthy-ori 3–1 transduced by a lentiviral vector containing the NRAS gene with the Q61R mutation. It was found that the expression of NRAS(Q61R) in thyroid epithelial cells has a profound influence on groups of genes involved in the formation of intercellular contacts, as well as in processes of epithelial–mesenchymal transition and cell invasion. The alteration in the expression of these genes affects the phenotype of the model cells, which acquire traits of mesenchymal cells and demonstrate increased ability for survival and growth without attachment to the substrate. The key regulators of these processes are transcription factors belonging to families SNAIL, ZEB, and TWIST, and in different types of tumors the contribution of each individual factor can vary greatly. In our model system, phenotype change correlates with an increase in the expression of SNAIL2 and TWIST2 factors, which indicates their possible role in regulating invasive growth of thyroid cancer with the mutation of NRAS(Q61R).
Similar content being viewed by others
Abbreviations
- EMT:
-
epithelial-mesenchymal transition
- TC:
-
thyroid cancer
References
Goodsell, D. S. (1999) The molecular perspective: the ras oncogene, Oncologist, 4, 263–264.
Fukushima, T., and Takenoshita, S. (2005) Roles of RAS and BRAF mutations in thyroid carcinogenesis, Fukushima J. Med. Sci., 51, 67–75.
Bhaijee, F., and Nikiforov, Y. E. (2011) Molecular analysis of thyroid tumors, Endocr. Pathol., 22, 126–133.
Nikiforov, Y. E., and Nikiforova, M. N. (2011) Molecular genetics and diagnosis of thyroid cancer, Nat. Rev. Endocr., 7, 569–580.
Jang, E. K., Song, D. E., Sim, S. Y., Kwon, H., Choi, Y. M., Jeon, M. J., Han, J. M., Kim, W. G., Kim, T. Y., Shong, Y. K., and Kim, W. B. (2014) NRAS codon 61 muta–tion is associated with distant metastasis in patients with follicular thyroid carcinoma, Thyroid, 24, 1275–1281.
Melo, M., Gaspar da Rocha, A., Batista, R., Vinagre, J., Martins, M. J., Costa, G., Ribeiro, C., Carrilho, F., Leite, V., Lobo, C., Cameselle–Teijeiro, J. M., Cavadas, B., Pereira, L., Sobrinho–Simoes, M., and Soares, P. (2017) TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease, J. Clin. Endocr. Metab., 102, 1898–1907.
Sohn, S. Y., Park, W. Y., Shin, H. T., Bae, J. S., Ki, C. S., Oh, Y. L., Kim, S. W., and Chung, J. H. (2016) Highly con–cordant key genetic alterations in primary tumors and matched distant metastases in differentiated thyroid cancer, Thyroid, 26, 672–682.
Gras, B., Jacqueroud, L., Wierinckx, A., Lamblot, C., Fauvet, F., Lachuer, J., Puisieux, A., and Ansieau, S. (2014) Snail family members unequally trigger EMT and thereby differ in their ability to promote the neoplastic transforma–tion of mammary epithelial cells, PLoS One, 9, e92254.
Cifone, M. A., and Fidler, I. J. (1980) Correlation of pat–terns of anchorage–independent growth with in vivo behav–ior of cells from a murine fibrosarcoma, Proc. Natl. Acad. Sci. USA, 77, 1039–1043.
Brabletz, T., Kalluri, R., Nieto, M. A., and Weinberg, R. A. (2018) EMT in cancer, Nat. Rev. Cancer, 18, 128–134.
Puisieux, A., Brabletz, T., and Caramel, J. (2014) Oncogenic roles of EMT–inducing transcription factors, Nat. Cell. Biol., 16, 488–494.
Cano, A., Perez–Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. (2000) The transcription factor snail controls epithe–lial–mesenchymal transitions by repressing E–cadherin expression, Nat. Cell. Biol., 2, 76–83.
Vu, T., and Datta, P. K. (2017) Regulation of EMT in colo–rectal cancer: a culprit in metastasis, Cancers (Basel), 9, E171.
Vasko, V., Espinosa, A. V., Scouten, W., He, H., Auer, H., Liyanarachchi, S., Larin, A., Savchenko, V., Francis, G. L., de la Chapelle, A., Saji, M., and Ringel, M. D. (2007) Gene expression and functional evidence of epithelial–to–mesenchymal transition in papillary thyroid carcinoma invasion, Proc. Natl. Acad. Sci. USA, 104, 2803–2808.
Lemoine, N. R., Mayall, E. S., Jones, T., Sheer, D., McDermid, S., Kendall–Taylor, P., and Wynford–Thomas, D. (1989) Characterization of human thyroid epithelial cells immortalized in vitro by simian virus 40 DNA trans–fection, Br. J. Cancer, 60, 897–903.
Khosravi–Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska–Wodnicka, M. (1996) Oncogenic Ras activation of Raf/mitogen–activated protein kinase–independent path–ways is sufficient to cause tumorigenic transformation, Mol. Cell. Biol., 16, 3923–3933.
Prokofjeva, M. M., Proshkina, G. M., Lebedev, T. D., Shulgin, A. A., Spirin, P. V., Prassolov, V. S., and Deyev, S. M. (2017) Lentiviral gene delivery to plasmolipin–express–ing cells using Mus caroli endogenous retrovirus envelope protein, Biochimie, 142, 226–233.
Schwartz, A. M., Putlyaeva, L. V., Covich, M., Klepikova, A. V., Akulich, K. A., Vorontsov, I. E., Korneev, K. V., Dmitriev, S. E., Polanovsky, O. L., Sidorenko, S. P., Kulakovskiy, I. V., and Kuprash, D. V. (2016) Early B–cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells, Biochim. Biophys. Acta, 1859, 1259–1268.
Afanasyeva, M. A., Britanova, L. V., Korneev, K. V., Mitkin, N. A., Kuchmiy, A. A., and Kuprash, D. V. (2014) Clusterin is a potential lymphotoxin beta receptor target that is upregulated and accumulates in germinal centers of mouse spleen during immune response, PLoS One, 9, e98349.
Kim, B. A., Jee, H. G., Yi, J. W., Kim, S. J., Chai, Y. J., Choi, J. Y., and Lee, K. E. (2017) Expression profiling of a human thyroid cell line stably expressing the BRAFV600E mutation, Cancer Genomics Proteomics, 14, 53–67.
Roskoski, R., Jr. (2012) ERK1/2 MAP kinases: structure, function, and regulation, Pharmacol. Res., 66, 105–143.
Pauta, M., Rotllan, N., Fernandez–Hernando, A., Langhi, C., Ribera, J., Lu, M., Boix, L., Bruix, J., Jimenez, W., Suarez, Y., Ford, D. A., Baldan, A., Birnbaum, M. J., Morales–Ruiz, M., and Fernandez–Hernando, C. (2016) Akt–mediated foxo1 inhibition is required for liver regener–ation, Hepatology, 63, 1660–1674.
Giordano, T. J., Kuick, R., Thomas, D. G., Misek, D. E., Vinco, M., Sanders, D., Zhu, Z., Ciampi, R., Roh, M., Shedden, K., Gauger, P., Doherty, G., Thompson, N. W., Hanash, S., Koenig, R. J., and Nikiforov, Y. E. (2005) Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation–specific gene expression profiles discovered by DNA microarray analysis, Oncogene, 24, 6646–6656.
Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44–57.
Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the compre–hensive functional analysis of large gene lists, Nucleic Acids Res., 37, 1–13.
Sponziello, M., Rosignolo, F., Celano, M., Maggisano, V., Pecce, V., De Rose, R. F., Lombardo, G. E., Durante, C., Filetti, S., Damante, G., Russo, D., and Bulotta, S. (2016) Fibronectin–1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells, Mol. Cell. Endocrinol., 431, 123–132.
Da, C., Wu, K., Yue, C., Bai, P., Wang, R., Wang, G., Zhao, M., Lv, Y., and Hou, P. (2017) N–cadherin promotes thyroid tumorigenesis through modulating major signaling pathways, Oncotarget, 8, 8131–8142.
Peng, X. G., Chen, Z. F., Zhang, K. J., Wang, P. G., Liu, Z. M., Chen, Z. J., Hou, G. Y., and Niu, M. (2015) VEGF Trapon inhibits tumor growth in papillary thyroid carcino–ma, Eur. Rev. Med. Pharmacol. Sci., 19, 235–240.
Kawakami, T., Tokunaga, T., Hatanaka, H., Kijima, H., Yamazaki, H., Abe, Y., Osamura, Y., Inoue, H., Ueyama, Y., and Nakamura, M. (2002) Neuropilin 1 and neuropilin 2 co–expression is significantly correlated with increased vascularity and poor prognosis in non–small cell lung carci–noma, Cancer, 95, 2196–2201.
Dowling, C. M., Hayes, S. L., Phelan, J. J., Cathcart, M. C., Finn, S. P., Mehigan, B., McCormick, P., Coffey, J. C., O’Sullivan, J., and Kiely, P. A. (2017) Expression of protein kinase C gamma promotes cell migration in colon cancer, Oncotarget, 8, 72096–72107.
Martin, T. A., Lane, J., Harrison, G. M., and Jiang, W. G. (2013) The expression of the Nectin complex in human breast cancer and the role of Nectin–3 in the control of tight junctions during metastasis, PLoS One, 8, e82696.
Kremenevskaja, N., von Wasielewski, R., Rao, A. S., Schofl, C., Andersson, T., and Brabant, G. (2005) Wnt–5a has tumor suppressor activity in thyroid carcinoma, Oncogene, 24, 2144–2154.
Kaur, S., Kroczynska, B., Sharma, B., Sassano, A., Arslan, A. D., Majchrzak–Kita, B., Stein, B. L., McMahon, B., Altman, J. K., Su, B., Calogero, R. A., Fish, E. N., and Platanias, L. C. (2014) Critical roles for Rictor/Sin1 com–plexes in interferon–dependent gene transcription and gen–eration of antiproliferative responses, J. Biol. Chem., 289, 6581–6591.
Kaur, S., Sassano, A., Majchrzak–Kita, B., Baker, D. P., Su, B., Fish, E. N., and Platanias, L. C. (2012) Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses, Proc. Natl. Acad. Sci. USA, 109, 7723–7728.
Cooney, R. N. (2002) Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway, Shock, 17, 83–90.
Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma, Cell, 159, 676–690.
Thiery, J. P., and Sleeman, J. P. (2006) Complex networks orchestrate epithelial–mesenchymal transitions, Nat. Rev. Mol. Cell. Biol., 7, 131–142.
Mueller, N., Wicklein, D., Eisenwort, G., Jawhar, M., Berger, D., Stefanzl, G., Greiner, G., Boehm, A., Kornauth, C., Muellauer, L., Sehner, S., Hoermann, G., Sperr, W. R., Staber, P. B., Jaeger, U., Zuber, J., Arock, M., Schumacher, U., Reiter, A., and Valent, P. (2018) CD44 is a RAS/STAT5–regulated invasion receptor that triggers dis–ease expansion in advanced mastocytosis, Blood, 132, 1936–1950.
Jia, L., Liu, W., Guan, L., Lu, M., and Wang, K. (2015) Inhibition of calcium–activated chloride channel ANO1/TMEM16A suppresses tumor growth and invasion in human lung cancer, PLoS One, 10, e0136584.
Drak Alsibai, K., and Meseure, D. (2018) Tumor microen–vironment and noncoding RNAs as co–drivers of epithelial–mesenchymal transition and cancer metastasis, Dev. Dyn., 247, 405–431.
Yoh, K. E., Regunath, K., Guzman, A., Lee, S. M., Pfister, N. T., Akanni, O., Kaufman, L. J., Prives, C., and Prywes, R. (2016) Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells, Proc. Natl. Acad. Sci. USA, 113, 6107–6116.
Kim, H., Choi, J. A., and Kim, J. H. (2014) Ras promotes transforming growth factor–beta (TGF–beta)–induced epithelial–mesenchymal transition via a leukotriene B4 receptor–2–linked cascade in mammary epithelial cells, J. Biol. Chem., 289, 22151–22160.
Wu, D., Zhao, B., Qi, X., Peng, F., Fu, H., Chi, X., Miao, Q. R., and Shao, S. (2018) Nogo–B receptor promotes epithelial–mesenchymal transition in non–small cell lung cancer cells through the Ras/ERK/Snail1 pathway, Cancer Lett., 418, 135–146.
Maiques, O., Barcelo, C., Panosa, A., Pijuan, J., Orgaz, J. L., Rodriguez–Hernandez, I., Matas–Nadal, C., Tell, G., Vilella, R., Fabra, A., Puig, S., Sanz–Moreno, V., Matias–Guiu, X., Canti, C., Herreros, J., Marti, R. M., and Macia, A. (2018) T–type calcium channels drive migration/inva–sion in BRAFV600E melanoma cells through Snail1, Pigment Cell. Melanoma Res., 31, 484–495.
Mittal, D., Gubin, M. M., Schreiber, R. D., and Smyth, M. J. (2014) New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape, Curr. Opin. Immunol., 27, 16–25.
Wang, R., Ma, Q., Ji, L., Yao, Y., Ma, M., and Wen, Q. (2018) miR–622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma, Onco. Targets Ther., 11, 1501–1509.
Sheng, L., Zhang, S., and Xu, H. (2017) Effect of slug–mediated down–regulation of E–cadherin on invasiveness and metastasis of anaplastic thyroid cancer cells, Med. Sci. Monit., 23, 138–143.
Borrello, M. G., Alberti, L., Fischer, A., Degl’innocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., Pilotti, S., Cassinelli, G., Bressan, P., Fugazzola, L., Mantovani, A., and Pierotti, M. A. (2005) Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene, Proc. Natl. Acad. Sci. USA, 102, 14825–14830.
Meng, X., Kong, D. H., Li, N., Zong, Z. H., Liu, B. Q., Du, Z. X., Guan, Y., Cao, L., and Wang, H. Q. (2014) Knockdown of BAG3 induces epithelial–mesenchymal transition in thyroid cancer cells through ZEB1 activation, Cell. Death. Dis., 5, e1092.
Author information
Authors and Affiliations
Corresponding author
Additional information
Russian Text © D. E. Demin, M. A. Afanasyeva, A. N. Uvarova, M. M. Prokofjeva, A. M. Gorbachova, A. S. Ustiugova, A. V. Klepikova, L. V. Putlyaeva, K. A. Tatosyan, P. V. Belousov, A. M. Schwartz, 2019, published in Biokhimiya, 2019, Vol. 84, No. 4, pp. 560–570.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM18–285, February 4, 2019.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Demin, D.E., Afanasyeva, M.A., Uvarova, A.N. et al. Constitutive Expression of NRAS with Q61R Driver Mutation Activates Processes of Epithelial–Mesenchymal Transition and Leads to Substantial Transcriptome Change of Nthy-ori 3–1 Thyroid Epithelial Cells. Biochemistry Moscow 84, 416–425 (2019). https://doi.org/10.1134/S0006297919040096
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297919040096